EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma

PMP Poortmans; JC Kluin-Nelemans; H Haaxma-Reiche; MB Veer; M Hansen; P Soubeyran; M Taphoorn; J Thomas; Martin van den Bent; M Fickers; G van Imhoff; C Rozewicz; I Teodorovic; M Glabbeke

EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma

PMP Poortmans, JC Kluin-Nelemans, H Haaxma-Reiche, MB Veer, M Hansen, P Soubeyran, M Taphoorn, J Thomas, Martin van den Bent, M Fickers, G van Imhoff, C Rozewicz, I Teodorovic, M Glabbeke

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	4483-4488
Number of pages	6
Journal	Journal of Clinical Oncology
Volume	21
Issue number	24
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Poortmans, PMP., Kluin-Nelemans, JC., Haaxma-Reiche, H., Veer, MB., Hansen, M., Soubeyran, P., Taphoorn, M., Thomas, J., van den Bent, M., Fickers, M., van Imhoff, G., Rozewicz, C., Teodorovic, I., & Glabbeke, M. (2003). EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma. Journal of Clinical Oncology, 21(24), 4483-4488.

@article{a2195462936348cbb8c7147e0ce65caf,

title = "EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma",

author = "PMP Poortmans and JC Kluin-Nelemans and H Haaxma-Reiche and MB Veer and M Hansen and P Soubeyran and M Taphoorn and J Thomas and {van den Bent}, Martin and M Fickers and {van Imhoff}, G and C Rozewicz and I Teodorovic and M Glabbeke",

year = "2003",

language = "Undefined/Unknown",

volume = "21",

pages = "4483--4488",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "24",

}

Poortmans, PMP, Kluin-Nelemans, JC, Haaxma-Reiche, H, Veer, MB, Hansen, M, Soubeyran, P, Taphoorn, M, Thomas, J, van den Bent, M, Fickers, M, van Imhoff, G, Rozewicz, C, Teodorovic, I & Glabbeke, M 2003, 'EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma', Journal of Clinical Oncology, vol. 21, no. 24, pp. 4483-4488.

EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma. / Poortmans, PMP; Kluin-Nelemans, JC; Haaxma-Reiche, H et al.

In: Journal of Clinical Oncology, Vol. 21, No. 24, 2003, p. 4483-4488.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - EORTC phase II trial 20962 evaluating high-dose MTX-based chemotherapy followed by consolidating radiotherapy in non-aids related primary central nervous system lymphoma

AU - Poortmans, PMP

AU - Kluin-Nelemans, JC

AU - Haaxma-Reiche, H

AU - Veer, MB

AU - Hansen, M

AU - Soubeyran, P

AU - Taphoorn, M

AU - Thomas, J

AU - van den Bent, Martin

AU - Fickers, M

AU - van Imhoff, G

AU - Rozewicz, C

AU - Teodorovic, I

AU - Glabbeke, M

PY - 2003

Y1 - 2003

M3 - Article

VL - 21

SP - 4483

EP - 4488

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 24

ER -